V030-5028 Screening compound: N-{[3-(2-furyl)-1,2,4-oxadiazol-5-yl]methyl}-1-cyclobutanecarboxamide
Chemical Structure Depiction of ChemDiv screening compound V030-5028
N-{[3-(2-furyl)-1,2,4-oxadiazol-5-yl]methyl}-1-cyclobutanecarboxamide
Available from 1 mg
Formats:
- Glass Vials (4ml Glass Vials VWR #97047-678)
- 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)
Shiptime: 1 week worldwide delivery in most cases
Compound Identifiers
ChemDiv Compound ID
V030-5028
Molecular Formula
C12H13N3O3 (C12 H13 N3 O3)
Compound Name
N-{[3-(2-furyl)-1,2,4-oxadiazol-5-yl]methyl}-1-cyclobutanecarboxamide
IUPAC name
N-{[3-(furan-2-yl)-124-oxadiazol-5-yl]methyl}cyclobutanecarboxamide
SMILES
O=C(C1CCC1)NCc1nc(-c2ccco2)no1
InChI Key
MDL Number (MFCD)
Chemical and Physical Properties
Saltdata
not_available
Molecular Weight
247.25
Hydrogen Bond Acceptors Count
6.00
Hydrogen Bond Donors Count
1.00
Rotatable Bond Count
5.00
Number of Nitrogen and Oxygen Atoms
6
Partition Coefficient, logP
0.896
Distribution Coefficient, logD
0.896
Water Solubility, LogSw
-1.48
Polar Surface Area
65.096
Acid Dissociation Constant (pKa)
13.15
Base Dissociation Constant (pKb)
-3.98
Number of Chiral Centers
0.00
Percent sp3 carbon bonding
41.67
References: we are preparing a list of scientific research reports with V030-5028 chemical compound. It will be published here after verification.
Frequently Asked Questions
Check Price and Availability of V030-5028, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
Available from 1 mg in Glass Vials or 96-tube racks.
ChemDiv sends parcels with Express services (UPS, WC).
- 1–2 days for small orders
- 2–4 weeks for large selections
- 0.5–50 mg of dry powder sample in single glass vials, custom vials
- DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)